CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 217 enrolled
Drug / intervention
Psychoeducation to reduce diabetes distress and improve glycemic outcomesbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05413239
NCT05413239N/ACompleted
CompareCT.gov

Improving Glycemia & Reducing Diabetes Distress in Adolescents & Young Adults With T1D: Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D)

Joslin Diabetes Center·interventional·Posted Jun 9, 2022·Updated Mar 12, 2026

In Brief

A clinical study evaluating Psychoeducation to reduce diabetes distress and improve glycemic outcomes for Type 1 Diabetes. Completed, enrolled 217 participants across 2 sites.

Detailed Summary

In this 2-year randomized clinical trial, we will implement and assess the impact of a behavioral/psychoeducational intervention to reduce diabetes distress and improve glycemic outcomes in adolescents and young adults, aged 14-25 years, with T1D in order to optimize their short-term and long-term health.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
CollaboratorsStanford University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 9, 2022
Enrollment StartJul 26, 2022
Primary CompletionNov 30, 2024
Study CompletionFeb 1, 2026
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 4.1 years ago

Interventions

Psychoeducation to reduce diabetes distress and improve glycemic outcomesbehavioral

The intervention includes two types of sessions - those targeting an improvement in glycemic outcomes and those targeting a reduction in diabetes distress. Evidence indicates that psychoeducation and support are needed to improve self-care behaviors and optimize use of advanced diabetes technologies, which, in turn, can help improve diabetes control while also reducing diabetes distress. Participants will receive 4 one-on-one glycemic sessions and 8 one-on-one distress sessions, each lasting \~30 minutes. Sessions will be conducted in-person or remotely. The virtual sessions are intended to provide the extra psychoeducation and support needed for this high risk group without increasing the burden associated with frequent face-to-face sessions.